All In Biotech

Drug Trial Radar · NCT05813678

A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)

A Multi-Center, Observational Study to Evaluate the Long-Term Safety of Subcutaneous Injections of Palynziq® (Pegvaliase) in Subjects With Phenylketonuria

Last checked: Nov 20, 2026Latest source record: Mar 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

450

Planned (sponsor's estimate)

Start

Jun 6, 2022

Primary completion

Nov 1, 2033

Study completion Nov 1, 2033

Sponsor

Lead sponsor
BioMarin PharmaceuticalBioMarin (BMRN)
Sponsor type
Industry
First posted
Apr 14, 2023

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a 10-year multi-center, global, observational study to further characterize the safety profile of pegvaliase, including hypersensitivity reactions, long-term safety and tolerability, and the effectiveness of the additional risk minimization measures (aRMMs) (European Union (EU) only) in subjects receiving pegvaliase for the treatment of PKU. Subjects for whom a clinical decision has been made that they will receive pegvaliase to treat their PKU within 30 days following the date of enrollment (incident-users) or have previously started treatment with pegvaliase at the date of enrollment (prevalent-users) are eligible for participation in this study.

Conditions

  • Phenylketonuria (PKU)

Interventions

  • PegvaliaseDrug

    This is an uncontrolled, single-cohort, Phase 4 observational study not falling under the definition of an Applicable Clinical Trial (ACT) (i.e., non-interventional).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To quantify and characterize the risk of protocol-defined safety events in incident-users receiving pegvaliase for the treatment of PKU in a real¬ world setting.Time frame: A maximum of 10 years treatment duration.

Locations

26 sites in 3 countries. Site status is shown where the registry gives one.

  • University of Colorado

    Aurora, Colorado · Recruiting

  • Emory University

    Atlanta, Georgia · Recruiting

  • Northwestern University

    Chicago, Illinois · Recruiting

  • Indiana University School of Medicine

    Indianapolis, Indiana · Recruiting

  • Tulane University Medical Center

    New Orleans, Louisiana · Recruiting

  • Boston Children's Hospital

    Boston, Massachusetts · Recruiting

  • Oregon Health and Science University

    Portland, Oregon · Recruiting

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania · Recruiting

  • Vanderbilt University Medical School

    Nashville, Tennessee · Recruiting

  • University of Texas Southwestern Medical Center

    Dallas, Texas · Recruiting

  • University of Utah

    Salt Lake City, Utah · Recruiting

  • Medical College of Wisconsin

    Milwaukee, Wisconsin · Recruiting

  • Hospital Carl-Thiem-Klinikum Cottbus

    Cottbus, Germany · Recruiting

  • Universitaetsklinikum Hamburg Eppendorf

    Hamburg, Germany · Recruiting

  • Universitaetslinikum Leipzig AoeR

    Leipzig, Germany · Recruiting

  • Johannes Gutenberg University of Mainz

    Mainz, Germany · Recruiting

  • Universitätsklinikum Münster (UKM)-Pädiatrische Universitätsklinik Münster

    Münster, Germany · Recruiting

  • Universität Ulm

    Ulm, Germany · Recruiting

  • Policlinico Sant'orsola Malpighi

    Bologna, Italy · Recruiting

  • University Hospital Careggi

    Florence, Italy · Recruiting

  • Ospedale San Paolo

    Milan, Italy · Recruiting

  • Azienda Ospedaliera Universitaria "Federico II" Dipartimento di Pediatria

    Naples, Italy · Recruiting

  • Azienda Ospedaliera di Padova

    Padova, Italy · Recruiting

  • Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone

    Palermo, Italy · Recruiting

  • Policlinico Gemelli

    Rome, Italy · Recruiting

  • Sapienza University of Rome Hospital

    Rome, Italy · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.